Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsXORTX Therapeutics, Inc. announced the closing of the acquisition of the Vectus kidney anti-fibrotic asset.
[XORTX Therapeutics, Inc.]
Home Newsletters Extracellular Matrix News XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
